-
公开(公告)号:US20230134936A1
公开(公告)日:2023-05-04
申请号:US17749015
申请日:2022-05-19
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Stephen J. Van Dien , Anthony P. Burgard , Wei Niu
IPC: C12N15/52 , C12N9/04 , C12N9/02 , C12N9/88 , C12N9/00 , C12P7/52 , C12P17/04 , B01D3/00 , C12P7/18 , C12P7/42 , C12N15/70 , C12N15/81
Abstract: The invention provides a non-naturally occurring microbial biocatalyst including a microbial organism having a 4-hydroxybutanoic acid (4-HB) biosynthetic pathway having at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, or α-ketoglutarate decarboxylase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce monomeric 4-hydroxybutanoic acid (4-HB). Also provided is a non-naturally occurring microbial biocatalyst including a microbial organism having 4-hydroxybutanoic acid (4-HB) and 1,4-butanediol (BDO) biosynthetic pathways, the pathways include at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, 4-hydroxybutyrate:CoA transferase, 4-butyrate kinase, phosphotransbutyrylase, α-ketoglutarate decarboxylase, aldehyde dehydrogenase, alcohol dehydrogenase or an aldehyde/alcohol dehydrogenase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce 1,4-butanediol (BDO). Additionally provided are methods for the production of 4-HB and BDO.
-
82.
公开(公告)号:US20230022727A1
公开(公告)日:2023-01-26
申请号:US17527902
申请日:2021-11-16
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.
-
83.
公开(公告)号:US11208673B2
公开(公告)日:2021-12-28
申请号:US16213671
申请日:2018-12-07
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.
-
公开(公告)号:US20210130861A1
公开(公告)日:2021-05-06
申请号:US16927396
申请日:2020-07-13
Applicant: Genomatica, Inc.
Inventor: Lauri H. Suominen , Connor J. Galleher , Michael Japs , Mark J. Burk , Cara Tracewell
Abstract: Provided is a method of producing and isolating a diamine produced by microbial fermentation that minimizes undesirable salt formation to provide a lower cost process.
-
公开(公告)号:US20200332320A1
公开(公告)日:2020-10-22
申请号:US16866405
申请日:2020-05-04
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Mark J. Burk
IPC: C12P7/44 , C08G63/183 , C12N9/02 , C12N9/04 , C12N9/10 , C12N9/12 , C12N9/88 , C12P7/24 , C12P7/40 , C12P9/00 , C07F9/09 , C07C51/43 , C12P7/62
Abstract: The invention provides non-naturally occurring microbial organisms having a (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate (2H3M4OP) pathway, p-toluate pathway, and/or terephthalate pathway. The invention additionally provides methods of using such organisms to produce 2H3M4OP, p-toluate or terephthalate. Also provided herein are processes for isolating bio-based aromatic carboxylic acid, in particular, p-toluic acid or terephthalic acid, from a culture medium, wherein the processes involve contacting the culture medium with sufficient carbon dioxide (CO2) to lower the pH of the culture medium to produce a precipitate comprised of the aromatic carboxylic acid.
-
86.
公开(公告)号:US10793882B2
公开(公告)日:2020-10-06
申请号:US15383941
申请日:2016-12-19
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Mark J. Burk
Abstract: The invention provides non-naturally occurring microbial organisms having a toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene pathway. The invention additionally provides methods of using such organisms to produce toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene.
-
87.
公开(公告)号:US20190276863A1
公开(公告)日:2019-09-12
申请号:US15971878
申请日:2018-05-04
Applicant: Genomatica, Inc.
Inventor: Jun Sun , Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Wei Niu , John D. Trawick , Robert Haselbeck
Abstract: The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.
-
公开(公告)号:US09988656B2
公开(公告)日:2018-06-05
申请号:US14954487
申请日:2015-11-30
Applicant: Genomatica, Inc.
Inventor: Jun Sun , Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Wei Niu , John D. Trawick , Robert Haselbeck
Abstract: The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.
-
公开(公告)号:US09708632B2
公开(公告)日:2017-07-18
申请号:US14673600
申请日:2015-03-30
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
IPC: C12P7/18 , C12P7/16 , C12N9/88 , C12N15/00 , C12N15/52 , C12N9/04 , C07C29/80 , C12N9/02 , C12N9/10
CPC classification number: C12P7/18 , C07C29/80 , C12N9/0006 , C12N9/0008 , C12N9/1029 , C12N9/1096 , C12N9/88 , C12N15/52 , C12Y101/01 , C12Y101/01157 , C12Y102/01 , C12Y203/01 , C12Y206/01 , C12Y401/01 , C12Y402/01 , C12Y403/01
Abstract: A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
-
90.
公开(公告)号:US09677045B2
公开(公告)日:2017-06-13
申请号:US13908907
申请日:2013-06-03
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya , Anthony P. Burgard , Stephen J. Van Dien , Robin E. Osterhout , Mark J. Burk , John D. Trawick , Michael P. Kuchinskas , Brian Steer
IPC: C12N1/20 , C12P7/42 , C12N15/63 , C12P7/18 , C12N9/18 , C12N15/52 , C07C31/20 , C07C59/01 , C08G18/28 , C08G18/32 , C08G63/06 , C08G63/16 , C08G63/181 , C08G69/02
CPC classification number: C12N1/20 , C07C31/207 , C07C59/01 , C08G18/284 , C08G18/3206 , C08G63/06 , C08G63/16 , C08G63/181 , C08G69/02 , C12N9/18 , C12N15/52 , C12N15/63 , C12P7/18 , C12P7/42 , C12Y301/01 , Y02P20/52
Abstract: The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate pathway and being capable of producing 4-hydroxybutyrate, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate or related products using the microbial organisms.
-
-
-
-
-
-
-
-
-